IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways

Overview of attention for article published in Frontiers in oncology, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

IL-22 confers EGFR-TKI resistance in NSCLC via the AKT and ERK signaling pathways

User montaukwhaler, in the non small cell lung cancer subreddit, 23 Oct 2019

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.